Mark Lawrence Johnson, PhD, MBA is a global health security economist and industry expert passionately dedicated to challenging the status quo concerning international availability and sustainability for countermeasures against chemical, biological, radiological, and nuclear (CBRN) agents and rare diseases. He would like to contribute to consortium projects by determining ways to strengthen the sustainability of relevant R&D public funding and defining/implementing the process to commercialize new products.

 Sustainable Development

 Pharmaceuticals

 Medical equipment

 International Cooperation

 Medical Biotechnology

 Industrial Design

 International Project Management

 Business Development

 Sociology and Economic Research

 Policy Evaluation and Governance